Innate Pharma SA
IPHA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001598599
No open-market purchases or sales by Innate Pharma SA insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $354.0K in total; no superinvestor holds it.
Other share classesIPHYF
Holders of 5% or more of IPHA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Innate Pharma SA, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Sanofi | 13G/A | 9.05%8.35M shares | 0.00 ppfrom 9.05% | Apr 29, 20252 filings | Apr 29, 2025 | SEC |
| AstraZeneca PLC | 13D/A | 8.30%7.83M shares | – | Feb 6, 20261 filing | Feb 6, 2026 | SEC |
| Bpifrance Participations SA | 13D/A | 7.90%7.32M shares | – | Feb 12, 20212 filings | May 7, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Innate Pharma SA, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 22, 20268:00 AM ET | Novo Nordisk A S | 13G/A | 0.00%0 shares | −5.03 ppfrom 5.03%Below 5% | May 29, 2026 | SEC |
| Apr 10, 20268:30 AM ET | Novo Nordisk A S | 13G/A | 5.03%4.72M shares | −2.79 ppfrom 7.82% | Mar 31, 2026 | SEC |
| Mar 4, 20264:45 PM ET | Novo Nordisk A S | 13G/A | 7.82%7.33M shares | −1.83 ppfrom 9.65% | Dec 31, 2025 | SEC |
| Feb 6, 20269:48 AM ET | AstraZeneca PLCand 1 other | 13D/A | 8.30%7.83M shares | – | Dec 22, 2025 | SEC |
| Oct 21, 20258:00 AM ET | Novo Nordisk A S | 13G/A | 9.65%8.90M shares | – | Jul 14, 2025 | SEC |
| May 7, 20254:02 PM ET | Bpifrance Participations SAand 4 others | 13D/A | 7.90%7.32M shares | – | Apr 25, 2025 | SEC |
| Apr 29, 20256:48 PM ET | Sanofi | 13G/A | 9.05%8.35M shares | 0.00 ppfrom 9.05% | Apr 23, 2025 | SEC |
| Apr 29, 20252:08 PM ET | Sanofi | 13G | 9.05%8.35M shares | New | Apr 23, 2025 | SEC |
| Feb 12, 2021 | Bpifrance Participations SA | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Innate Pharma SA shares.
No Form 144 notices for Innate Pharma SA are on file.